Target Price | $326.40 |
Price | $307.95 |
Potential | 5.99% |
Number of Estimates | 28 |
28 Analysts have issued a price target American Express 2026 . The average American Express target price is $326.40. This is 5.99% higher than the current stock price. The highest price target is $389.55 26.50% , the lowest is $242.40 21.29% . | |
A rating was issued by 35 analysts: 15 Analysts recommend American Express to buy, 19 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the American Express stock has an average upside potential 2026 of 5.99% . Most analysts recommend the American Express stock at Hold. |
27 Analysts have issued a sales forecast American Express 2025 . The average American Express sales estimate is $72.0b . This is 0.97% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $75.4b 3.64% , the lowest is $69.4b 4.61% .
This results in the following potential growth metrics:
2024 | $71.6b | 9.58% |
---|---|---|
2025 | $72.0b | 0.52% |
2026 | $77.8b | 8.02% |
2027 | $83.7b | 7.66% |
2028 | $88.8b | 6.01% |
2029 | $95.1b | 7.12% |
4 Analysts have issued an American Express EBITDA forecast 2025. The average American Express EBITDA estimate is $26.9b . This is 82.92% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $28.0b 90.17% , the lowest is $26.1b 77.49% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.1b | 13.28% |
---|---|---|
2025 | $26.9b | 91.21% |
2026 | $18.8b | 29.98% |
2027 | $24.5b | 30.13% |
2024 | 19.63% | 3.37% |
---|---|---|
2025 | 37.33% | 90.20% |
2026 | 24.20% | 35.17% |
2027 | 29.25% | 20.87% |
31 American Express Analysts have issued a net profit forecast 2025. The average American Express net profit estimate is $10.8b . This is 6.33% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $11.5b 13.58% , the lowest is $9.9b 2.01% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.0b | 21.12% |
---|---|---|
2025 | $10.8b | 7.90% |
2026 | $12.3b | 13.96% |
2027 | $14.0b | 14.20% |
2028 | $14.4b | 2.84% |
2029 | $15.3b | 6.35% |
2024 | 13.95% | 10.53% |
---|---|---|
2025 | 14.98% | 7.38% |
2026 | 15.80% | 5.47% |
2027 | 16.76% | 6.08% |
2028 | 16.26% | 2.98% |
2029 | 16.14% | 0.74% |
31 Analysts have issued a American Express forecast for earnings per share. The average American Express EPS is $15.38 . This is 6.51% higher than earnings per share in the financial year 2024. The highest EPS forecast is $16.43 13.78% , the lowest is $14.18 1.80% .
This results in the following potential growth metrics and future valuations:
2024 | $14.02 | 25.07% |
---|---|---|
2025 | $15.38 | 9.70% |
2026 | $17.53 | 13.98% |
2027 | $20.02 | 14.20% |
2028 | $20.59 | 2.85% |
2029 | $21.90 | 6.36% |
Current | 21.33 | 20.92% |
---|---|---|
2025 | 20.02 | 6.12% |
2026 | 17.57 | 12.24% |
2027 | 15.38 | 12.46% |
2028 | 14.96 | 2.73% |
2029 | 14.06 | 6.02% |
Based on analysts' sales estimates for 2025, the American Express stock is valued at an EV/Sales of 5.04 and an P/S ratio of 3.00 .
This results in the following potential growth metrics and future valuations:
Current | 4.99 | 12.13% |
---|---|---|
2025 | 5.04 | 0.98% |
2026 | 4.67 | 7.42% |
2027 | 4.33 | 7.11% |
2028 | 4.09 | 5.67% |
2029 | 3.82 | 6.64% |
Current | 2.97 | 18.99% |
---|---|---|
2025 | 3.00 | 0.98% |
2026 | 2.77 | 7.42% |
2027 | 2.58 | 7.11% |
2028 | 2.43 | 5.67% |
2029 | 2.27 | 6.65% |
American Express...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | Jul 11 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 10 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Jul 09 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Jul 09 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jul 08 2025 |
Citigroup |
Neutral
➜
Neutral
|
Unchanged | Jul 02 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | May 23 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
Jul 11 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Jul 10 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Jul 09 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Jul 09 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jul 08 2025 |
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Jul 02 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
May 23 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.